InMed Pharmaceuticals Inc (INM)
0.303
+0.03
(+10.99%)
USD |
NASDAQ |
Apr 24, 16:00
0.281
-0.02
(-7.26%)
After-Hours: 06:16
InMed Pharmaceuticals Cash from Operations (Quarterly): -1.848M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | -1.848M |
September 30, 2023 | -2.174M |
June 30, 2023 | -0.6579M |
March 31, 2023 | -1.657M |
December 31, 2022 | -2.713M |
September 30, 2022 | -2.256M |
June 30, 2022 | -4.047M |
March 31, 2022 | -5.349M |
December 31, 2021 | -3.534M |
September 30, 2021 | -2.654M |
June 30, 2021 | -2.006M |
March 31, 2021 | -4.612M |
December 31, 2020 | -1.801M |
September 30, 2020 | -1.372M |
June 30, 2020 | -1.399M |
March 31, 2020 | -1.521M |
December 31, 2019 | -2.09M |
September 30, 2019 | -2.365M |
June 30, 2019 | -1.915M |
March 31, 2019 | -2.139M |
December 31, 2018 | -1.293M |
September 30, 2018 | -1.333M |
June 30, 2018 | -0.9935M |
March 31, 2018 | -0.6773M |
December 31, 2017 | -0.7937M |
Date | Value |
---|---|
September 30, 2017 | -1.088M |
June 30, 2017 | -0.8244M |
March 31, 2017 | -0.7369M |
December 31, 2016 | -0.6392M |
September 30, 2016 | -0.165M |
June 30, 2016 | -0.0952M |
March 31, 2016 | -0.06M |
December 31, 2015 | -0.1035M |
September 30, 2015 | -0.1274M |
June 30, 2015 | -0.7596M |
March 31, 2015 | -0.6587M |
December 31, 2014 | -0.0866M |
September 30, 2014 | -0.1026M |
June 30, 2014 | -0.6388M |
March 31, 2014 | 0.0006M |
December 31, 2013 | -0.0004M |
September 30, 2013 | -0.0028M |
June 30, 2013 | 0.0034M |
March 31, 2013 | 0.0009M |
December 31, 2012 | -0.0157M |
September 30, 2012 | -0.0279M |
June 30, 2012 | -0.0401M |
March 31, 2012 | -0.0183M |
December 31, 2011 | -0.0761M |
September 30, 2011 | -0.0401M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-5.349M
Minimum
Mar 2022
-0.6579M
Maximum
Jun 2023
-2.419M
Average
-2.09M
Median
Dec 2019
Cash from Operations (Quarterly) Benchmarks
Rimrock Gold Corp | -0.0386M |
Venus Concept Inc | -- |
Juva Life Inc | -0.5406M |
CEN Biotech Inc | 0.1023M |
Lucy Scientific Discovery Inc | -0.7395M |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -0.0093M |
Cash from Financing (Quarterly) | 4.654M |
Free Cash Flow | -6.508M |
Free Cash Flow Per Share (Quarterly) | -0.233 |
Free Cash Flow to Equity (Quarterly) | -1.857M |
Free Cash Flow to Firm (Quarterly) | -1.857M |
Free Cash Flow Yield | -478.5% |